Common cardiovascular biomarkers can independently predict outcome of patients with Myelodysplastic syndromes

被引：2
|
作者：
Mitroulis, Ioannis [1 ,2 ,3 ]
Papadopoulos, Vasileios [1 ]
Lamprianidou, Eleftheria [1 ]
Mirtschink, Peter [2 ,3 ]
Liapis, Konstantinos [1 ]
Zafeiropoulou, Kalliopi [4 ]
Kourakli, Alexandra [4 ]
Moysiadis, Theodoros [5 ]
Papoutselis, Menelaos [1 ]
Vrachiolias, George [1 ]
Symeonidis, Argiris [4 ]
Kotsianidis, Ioannis [1 ]
机构：
[1] Democritus Univ Thrace, Dept Hematol, Med Sch, Alexandroupolis, Greece
[2] Univ Hosp, Inst Clin Chem & Lab Med, Dresden, Germany
[3] Tech Univ Dresden, Fac Med Carl Gustav Carus, Dresden, Germany
[4] Univ Patras, Dept Internal Med, Hematol Div, Med Sch, Patras, Greece
[5] Univ Nicosia, Sch Sci & Engn, Dept Comp Sci, CY-2417 Nicosia, Cyprus
来源：
BLOOD CANCER JOURNAL | 2023年 / 13卷 / 01期
关键词：
CLONAL HEMATOPOIESIS; RISK; CANCER;
D O I：
10.1038/s41408-023-00844-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Monosomal karyotype predicts inferior survival independently of a complex karyotype in patients with myelodysplastic syndromes
    McQuilten, Zoe K.
    Sundararajan, Vijaya
    Andrianopoulos, Nick
    Curtis, David J.
    Wood, Erica M.
    Campbell, Lynda J.
    Wall, Meaghan
    CANCER, 2015, 121 (17) : 2892 - 2899
  • [32] Fracture non-union: Can biomarkers predict outcome?
    Pountos, I.
    Georgouli, T.
    Pneumaticos, S.
    Giannoudis, P. V.
    INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 2013, 44 (12): : 1725 - 1732
  • [33] Can we predict outcome in schizophrenia? The need for prognostic biomarkers
    Mehta, Urvakhsh Meherwan
    Keshavan, Matcheri S.
    ASIAN JOURNAL OF PSYCHIATRY, 2015, 14 : 1 - 2
  • [34] Can biomarkers predict clinical disease outcome in knee osteoarthritis?
    Sharif, Mohammed
    Fasham, James
    Johansen, Julia
    Karl, Johann
    Davis, Chris R.
    Granell, Raquel
    Kirwan, John R.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S137 - S138
  • [35] Estimated glomerular filtration rate independently predicts outcome of azacitidine therapy in higher-risk Myelodysplastic syndromes. Results from 536 patients of the Hellenic National Registry of Myelodysplastic and Hypoplastic syndromes
    Papadopoulos, Vasileios
    Diamantopoulos, Panagiotis T.
    Papageorgiou, Sotirios G.
    Papoutselis, Menelaos
    Vrachiolias, George
    Pappa, Vassiliki
    Galanopoulos, Athanasios G.
    Vassilakopoulos, Theodoros P.
    Hatzimichael, Eleftheria
    Zikos, Panagiotis
    Papadaki, Helen A.
    Bouchla, Anthi
    Panayiotidis, Panayiotis
    Megalakaki, Aekaterini
    Papaioannou, Maria
    Liapis, Konstantinos
    Dryllis, George
    Tsokanas, Dimitris
    Kourakli, Alexandra
    Symeonidis, Argiris
    Viniou, Nora-Athina
    Kotsianidis, Ioannis
    HEMATOLOGICAL ONCOLOGY, 2020, 38 (04) : 541 - 553
  • [36] PROGNOSTIC MARKERS THAT PREDICT THE OUTCOME OF REDUCED INTENSITY CONDITIONING TRANSPLANT IN ADULT PATIENTS WITH MYELODYSPLASTIC SYNDROMES: A SINGLE CENTER EXPERIENCE
    Elashwah, S.
    Shamaa, S.
    Kamel, H.
    Samra, M.
    Azmy, E.
    HAEMATOLOGICA, 2017, 102 : 767 - 767
  • [37] Anaemia to predict outcome in patients with acute coronary syndromes
    Ennezat, Pierre Vladimir
    Marechaux, Sylvestre
    Pincon, Claire
    Finzi, Jonathan
    Barrailler, Stephanie
    Bouabdallaoui, Nadia
    Van Belle, Eric
    Montalescot, Gilles
    Collet, Jean-Philippe
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2013, 106 (6-7) : 357 - 365
  • [38] Possible Biomarkers To Predict Response In Patients With Myelodysplastic Syndromes (MDS) Or Acute Myeloid Leukemia (AML) Treated With 5-Azacitidine
    Kuendgen, Andrea
    Mueller-Thomas, Catharina
    Urbaniak, Petra
    Lauseker, Michael
    Haferlach, Torsten
    Alpermann, Tamara
    Albuquerque, Andreia
    Kohlmann, Alexander
    Schnittger, Susanne
    Hildebrandt, Barbara
    Royer-Pokora, Brigitte
    Gattermann, Norbert
    Haas, Rainer
    Germing, Ulrich
    Goetze, Katharina
    BLOOD, 2013, 122 (21)
  • [39] Wt1 expression and clinical outcome in patients with myelodysplastic syndromes
    Villa, M. R.
    Esposito, M.
    Improta, S.
    Lucania, A.
    Sagristani, M.
    Latte, A.
    Polistina, M. T.
    Mastrullo, T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 160 - 160
  • [40] Outcome of Patients Treated for Myelodysplastic Syndromes after Failure of Lenalidomide Therapy
    Prebet, Thomas
    Cluzeau, Thomas
    Park, Sophie
    Germing, Ulrich
    Ades, Lionel
    Platzbecker, Uwe
    Vey, Norbert
    Goetze, Katharina
    Kelaidi, Charikleia
    Oliva, Esther Natalie
    Al Ali, Najla H.
    Fenaux, Pierre
    Gore, Steven D.
    Komrokji, Rami S.
    BLOOD, 2015, 126 (23)
12345